Choose a folder
Publication milestones for DISCOVER
The DISCOVER methods and rationale manuscript has been accepted for publication, and first baseline results were presented at the 77th Scientific Sessions of the American Diabetes Association.
The DISCOVER study team is proud to announce that a manuscript describing the methods and rationale of the DISCOVER study programme has been accepted for publication in the Journal of Diabetes and its Complications. DISCOVER is a prospective, observational study of more than 16 000 patients with type 2 diabetes who are starting a second-line glucose-lowering therapy across 38 countries and six continents. This article will be an important reference for future DISCOVER publications, and describes key features of the study design and implementation. It also highlights the great diversity of physicians (Figure 1) and sites (Figure 2) involved in this novel and ambitious study, which will provide insights on the management of patients with type 2 diabetes in a wide range of clinical settings. To read more, please click here.
We’d like to thank the DISCOVER investigators for their tremendous data collection efforts. The first baseline results were presented at the 77th Scientific Sessions of the American Diabetes Association, 9–13 June, San Diego, CA, USA. The presentations on global levels of glycated haemoglobin (HbA 1c), prevalence of complications, and selection of glucose-lowering medication in patients with type 2 diabetes initiating second-line treatment were very well received. For the full details of these presentations and further publication updates, please keep visiting the DISCOVER website.
Additional information about ADA 2017 is available on the congress website at: http://professional.diabetes.org/meeting/scientific-sessions/77th-scientific-sessions
Figure 1. Specialty of DISCOVER investigators
Figure 2. Type of DISCOVER sites